After many years of preparation, 2021 has been identified as the year marking the position of DHG Pharma in the international market.

While many enterprises are struggling with problems of staff reductions and cost optimization, DHG Pharmaceutical Joint-Stock Company (DHG) is still persistent with its plan to become the leading company in order to bring Vietnamese pharmaceutical industry to the world market. For the past 5 years, the enterprise has continuously been leading in a race of international technology, human and quality innovation, making a practical contribution to the realization of export target of USD1 billion in pharmaceutical products in 2030 that the Government has set.

The year 2020 had a significant impact on the pharmaceutical industry, but many enterprises have made their efforts to overcome waves successfully and find their own way.

The year 2020 marked an important transformation of DHG Pharma in improving quality and increasing competitiveness of global GMP standard products. This is a breakthrough step for global integration of DHG Pharma with the mission of raising the level of Vietnamese medicines not only in the domestic market but also firmly reaching the international market, thereby raising the position of DHG Pharma on the world prestigious pharmaceutical enterprise map, increasing benefits for stakeholders while improving the health and quality of life of millions of people.

For providing knowledge about health and how to prevent stroke to close customers in hot season. In Mar 24, Can Tho city, DHG Pharma and NattoEnzym Red Rice organized a science workshop “SOLUTIONS TO CONTROL AND PREVENT STROKE” with the participation of Dr. Tran Chi Cuong - President of the Nervous Intervention Society of HCM, AAFITN Executive Committee, Specialist Director of S.I.S Hospital in Can Tho to share useful information. Dr. Tran Chi Cuong shared about the danger of stroke, risks, how to prevent stroke and treatments.

In the context of late 2020 and early 2021, free trade agreements open up more challenges than opportunities for domestic pharmaceutical companies, but many enterprises still find their own key to open this door.

Over the past decade, Vietnam’s pharmaceutical market has continuously increased due to the impact of economic agreements such as CPTPP, EVFTA, WTO, ATIGA, VJEPA, etc.

Over the years, some enterprises have successfully built up international distribution networks. Prominent is DHG Pharma which brings many its products to Singapore, Moldova, Russia, and Southeast Asia.

On the morning of March 21, 2021 at DHG Pharma, a launching of online walking race BE HEALTHY BOCALEX 2021 happened with the presence of DHG Pharma’s leaders, Youth Union of Businesses’ sector and more than 50 youth union members representing DHG Pharma and fellow enterprises.

The online waking race is hold by Bocalex (DHG Pharma) in collaboration with Can Tho City Youth Union of Businesses’ Sector with a target: Celebrating the 90th anniversary of the establishment of the Ho Chi Minh Communist Youth Union (26/03/1931 - 26/03/2021). Creating a useful activity for youth members of enterprises in Can Tho city and DHG Pharma nationwide. Since then, spreading and creating a positive influence to people about sports training and health protection.

The Taisho and DHG story is a “sweet fruit” of the post-M&A pharmaceutical industry, after 5 years of starting to build a solid foundation for DHG Pharma’s international breakthroughs reaching the world.

For DHG Pharma, the year 2020 has become an unforgettable year, a year that affirmed the spirit of resilience, courage, and silent contributions of "white-shirted soldiers" in the fight against the Covid-19 epidemic.Although there were periods which the epidemic "heated" up and then lulled, the treatment and researching on vaccines for patients has never been less stressful. With the endless effort and dedication to the community, white-shirted soldiers on all fronts have contributed to build up the image of a medical personnel "excellence on the professional knowledge and skills – abundance of medical ethics". This spirit continues to be expressed on the early days of the year 2021 when the Covid-19 epidemic broke out again.

After 5 years of cooperation, the result of 2 tablet and film-coated tablet production lines achieving Japan-GMP certification in 2019 and 2020 has created a mark in the pharmaceutical industry, also showing that Taisho’s aspiration in committing to accompany DHG Pharma.